Onpattro Now Approved: Patient and HCP-facing pages




Brand: Onpattro (patisiran), Injection
Parent Company: Alnylam
Drug Type: Prescription
Drug Category: Immunology
Campaign: now-approved
Targeting: HCPs, Patients, Caregivers
Patient Website: https://www.onpattro.com/
HCP Website: https://www.onpattro.com/hcp/